Page 100 - Total War on PTSD

Post-Traumatic Stress Disorder. Dr. Tuorila has been active in testing and study of the positive results of AtEase Glasses for PTSD.
The results of all studies have proven to be very positive. We have learned that the Delta and Theta waves are the lowest frequency brain waves and are typically only experienced during deep sleep. These are the waves that become active during the production of dreams. Alpha waves are typically prominent in an adult who is awake but relaxed with their eyes closed. In general, amplitudes diminish when subjects open their eyes and are attentive to external stimuli. Unfortunately for victims of PTSD, Delta, Theta, and Alpha waves can increase activity during wake time, leading to vivid flashbacks and intense emotional reactions that cannot be differentiated from the present.
AtEase products have been designed to provide therapeutic relief for illnesses that can be treated using visual tools rather than pharmaceutical products. AtEase is accomplishing this every day using the scientific technology delivered through the highly specialized, patented and FDA approved glasses. The glasses use a precisely manufactured lens with unique color coating and modified visual field. Having our mission to improve the lives of people impacted by chronic conditions and those seeking enhanced performance through a drug-free and non-invasive approach, that calms, soothes and focuses the brain drives us to evolve and deliver the best products and services that we can. To the world, this product looks like the coolest sunglasses of the season. To the wearer, these lenses calm and focus the brain, resulting in improved performance in life, work and play.
Optometry is normally concerned with ocular health and correction of eye problems such as vision and visual systems that can hinder the sight in humans. In the optometry industry, the demand is governed by changing healthcare practices, eyewear fashion trends and demographics. There is significant demand for leading edge technical solutions to fill the need for productive treatment in this field. The total vision care market in the United States generated about 34.54 billion U.S. dollars, with annual services expenditures growing toward $40 billion annually. With the development of
100 of 1063